Bekim Bajrami

Company: Biogen

Job title: Associate Scientific Director

Seminars:

Pre-clinical Characterization of Orally Bioavailable CNS-Penetrant Degraders for the Treatment of Multiple Sclerosis 1:15 pm

Selectivity Profiling: Assessing the specificity of the degrader candidate across a range of targets Target Engagement Assays: Measuring the binding and interaction of the degrader candidate with its intended targetRead more

day: Conference Day 2